When: Wednesday, November 5, at 6:30 CT
Description: An overview of severe primary IGF-1 deficiency and its treatment option.
Learning Objectives:
Review the role of growth hormone and IGF-1 in growth and understand the pathophysiology and differential diagnosis of primary and severe primary IGF-1 deficiency (SPIGFD).
Explore the clinical profile of Increlex® for SPIGFD, including its indication, mechanism of action, efficacy, safety, and practical guidance on dosing and administration.
Speaker:
Dr. Phillipe Backeljauw
Professor of Clinical Pediatrics
University of Cincinnati College of Medicine
Cincinnati Children’s Hospital Medical Center
Division of Pediatric Endocrinology
Sponsored By: eTon Pharmaceuticals